ATE155689T1 - Aktivätsmessungen des amylin - Google Patents

Aktivätsmessungen des amylin

Info

Publication number
ATE155689T1
ATE155689T1 AT92904180T AT92904180T ATE155689T1 AT E155689 T1 ATE155689 T1 AT E155689T1 AT 92904180 T AT92904180 T AT 92904180T AT 92904180 T AT92904180 T AT 92904180T AT E155689 T1 ATE155689 T1 AT E155689T1
Authority
AT
Austria
Prior art keywords
amylin
rise
lactate
simulate
determining
Prior art date
Application number
AT92904180T
Other languages
English (en)
Inventor
Andrew Young
Garth James Smith Cooper
Timothy J Rink
Original Assignee
Amylin Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/640,478 external-priority patent/US5234906A/en
Application filed by Amylin Pharmaceuticals Inc filed Critical Amylin Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE155689T1 publication Critical patent/ATE155689T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT92904180T 1991-01-10 1992-01-10 Aktivätsmessungen des amylin ATE155689T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/640,478 US5234906A (en) 1991-01-10 1991-01-10 Hyperglycemic compositions
US66652791A 1991-03-08 1991-03-08

Publications (1)

Publication Number Publication Date
ATE155689T1 true ATE155689T1 (de) 1997-08-15

Family

ID=27093565

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92904180T ATE155689T1 (de) 1991-01-10 1992-01-10 Aktivätsmessungen des amylin

Country Status (10)

Country Link
US (1) US6048514A (de)
EP (1) EP0525149B1 (de)
JP (1) JP2818296B2 (de)
AT (1) ATE155689T1 (de)
CA (1) CA2077265A1 (de)
DE (1) DE69221040T2 (de)
DK (1) DK0525149T3 (de)
ES (1) ES2107528T3 (de)
GR (1) GR3024812T3 (de)
WO (1) WO1992011863A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU222249B1 (hu) 1991-03-08 2003-05-28 Amylin Pharmaceuticals Inc. Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
WO1993023435A1 (en) * 1992-05-15 1993-11-25 Amylin Pharmaceuticals, Inc. Antibody assay for amylin
AU6249594A (en) * 1993-02-12 1994-08-29 Amylin Pharmaceuticals, Inc. Mcf-7 binding site assays
US6936584B1 (en) 1998-02-13 2005-08-30 Amylin Pharmaceuticals, Inc. Mixed amylin activity compounds
US20040038861A1 (en) * 2001-11-26 2004-02-26 Cooper Garth J. S. Methods and compositions for normalizing lipid levels in mammalian tissues
US20040142393A1 (en) * 2002-08-01 2004-07-22 Cooper Garth James Smith Methods of use of compounds with preptin function
US7339347B2 (en) * 2003-08-11 2008-03-04 Reserve Power Cell, Llc Apparatus and method for reliably supplying electrical energy to an electrical system
EP1719447A1 (de) * 2005-05-07 2006-11-08 F. Hoffmann-La Roche AG Verfahren und Vorrichtung zur Bestimmung der Glucose-Konzentration in Gewebflüssigkeit
JP2010536822A (ja) * 2007-08-24 2010-12-02 ビーエーエスエフ ソシエタス・ヨーロピア ベンゾトリアゾールとメロシアニンを含む混合物
JP6358942B2 (ja) * 2014-12-05 2018-07-18 沢井製薬株式会社 エンドトキシンの測定用試薬及びエンドトキシンの測定方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8316032D0 (en) * 1983-06-11 1983-07-13 Tanabe Seiyaku Co Benzothiazepine derivatives
US5266561A (en) * 1988-01-11 1993-11-30 Amylin Pharmaceuticals, Inc. Treatment of type 2 diabetes mellitus
US5280014A (en) * 1988-01-11 1994-01-18 Amylin Pharmaceuticals, Inc. Treatment of obesity and essential hypertension and related disorders
US5260275A (en) * 1990-08-14 1993-11-09 Amylin Pharmaceuticals, Inc. Hypoglycemics
US5234906A (en) * 1991-01-10 1993-08-10 Amylin Pharmaceuticals, Inc. Hyperglycemic compositions
US5321008A (en) * 1991-01-10 1994-06-14 Amylin Pharmaceuticals, Inc. Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions
US5376638A (en) * 1992-09-01 1994-12-27 Amylin Pharmaceuticals, Inc. Methods for treating renin-related disorders with amylin antagonists

Also Published As

Publication number Publication date
DK0525149T3 (da) 1997-12-01
ES2107528T3 (es) 1997-12-01
US6048514A (en) 2000-04-11
JP2818296B2 (ja) 1998-10-30
CA2077265A1 (en) 1992-07-11
WO1992011863A1 (en) 1992-07-23
EP0525149B1 (de) 1997-07-23
EP0525149A1 (de) 1993-02-03
EP0525149A4 (en) 1993-08-25
DE69221040T2 (de) 1997-11-13
JPH05505625A (ja) 1993-08-19
GR3024812T3 (en) 1998-01-30
DE69221040D1 (de) 1997-09-04

Similar Documents

Publication Publication Date Title
TW369599B (en) A reagent strip and a method for measuring glucose concentration in a sample of whole blood
ATE245937T1 (de) Überwachung physiologischer analyte
RU2002113055A (ru) Тестирующая полоска с реагентом для определения содержания анализируемого вещества
TWI256975B (en) Compositions containing a urea derivative dye for detecting an analyte and methods for using the same
EP0140322A3 (en) Polymer catalyst transducers and use thereof in test kits for analytical methods
ATE328661T1 (de) Einschubkassette für drogenmissbrauchprüfbecher
ATE4127T1 (de) Testprobe zum messen von glukose.
AU2303195A (en) Process and device for the analysis of glucose in a biological sample
SE8804074D0 (sv) Sensorenhet och dess anvaendning i biosensorsystem
ATE290693T1 (de) Teststreifen zur bestimmung eines analyts in eine flüssige probe
DE69920940D1 (de) Verfahren zur überwachung der proteasomeinhibitorarzneimitteleffekte
DK0444273T3 (da) Sammensætning, anordning og fremgangsmåde til analyse for et peroxidativt aktivt stof
ATA114789A (de) Verfahren und vorrichtung zur feststellung biologischer aktivitaeten in einer probe
CA2235316A1 (en) A method for detecting antipolymer antibodies and a diagnostic test kit for use in aiding the diagnosis of silicone related diseases (srd)
KR880004314A (ko) 생리 활성물질 측정법
EP0353985A3 (de) Nukleinsäureprobe zur Detektion von Neisseria gonorrhoea
DE69221040D1 (de) Aktivätsmessungen des amylin
NO950426D0 (no) Analyse for bestemmelse av protein i en biologisk pröve
NO953770L (no) Analysemetode
GB2212269B (en) Rheometrics and viscoelastic measurement
ES2067024T3 (es) Metodo y kit para determinar actividades fosforilantes y desfosforilantes de tirosina.
EP0632133A4 (de) Hochempfindliche bestimmung von d-3-hydroxybutiersäure oder acetessigsäure und zusammensetzung dafür.
DE69229954D1 (de) Nukleinsäurenachweis
NO920624L (no) Reagens for paavisning av fibrinolytisk aktivitet
Underwood Dose-response tests in field surveys

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee